We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $559M Turnover 17.24%
1-Year Est. Return 83.7%
This Fund
S&P 500
This Quarter Est. Return
+8.56%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$559M
AUM Growth
-$19.6M
Cap. Flow
+$14.4M
Cap. Flow %
2.58%
Top 10 Hldgs %
77.52%
Holding
87
New
6
Increased
9
Reduced
8
Closed
9
Avg Time Held
2.7 years
Top 10 Avg Time Held
2.3 years
Top 20 Avg Time Held
2.5 years

Top Buys

Rank Stock Value
1
LIQT icon
LiqTech
LIQT
+$5.92M
2
COGT icon
Cogent Biosciences
COGT
+$3.5M
3
CUE icon
Cue Biopharma
CUE
+$3.24M
4
SPIR icon
Spire Global
SPIR
+$2.51M
5
DTIL icon
Precision BioSciences
DTIL
+$2.5M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$4.07M
2
JPM icon
JPMorgan Chase
JPM
+$1.49M
3
POCI icon
Precision Optics
POCI
+$1.19M
4
RTX icon
RTX Corp
RTX
+$1.16M
5
FLNT icon
Fluent
FLNT
+$831K

Sector Composition

Rank Sector Weight
1 Miscellaneous 41.42%
2 Industrials 22.38%
3 Healthcare 17.16%
4 Technology 6.03%
5 Materials 5.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
OPFI.WS icon
76
DELISTED
OppFi Inc Warrants
OPFI.WS
$7.5K ﹤0.01%
250,000
– –
2021 Q3
19 quarters
XFOR icon
77
X4 Pharmaceuticals
XFOR
$256M
$2.78K ﹤0.01%
595
– –
2019 Q4
26 quarters
SVREW icon
78
SaverOne 2014 Ltd Warrant
SVREW
$1.33K ﹤0.01%
121,000
– –
2022 Q2
16 quarters
AVNW icon
79
Aviat Networks
AVNW
$250M
– –
-66
Closed -$1.49K –
CARR icon
80
Carrier Global
CARR
$44.8B
– –
-6,000
Closed -$338K –
ERNA icon
81
Eterna Therapeutics
ERNA
$2.39M
– –
-80,000
Closed -$398K –
LHX icon
82
L3Harris
LHX
$44.8B
– –
-1,600
Closed -$552K –
OTIS icon
83
Otis Worldwide
OTIS
$26.7B
– –
-3,000
Closed -$231K –
POCI icon
84
Precision Optics
POCI
$48M
– –
-270,925
Closed -$1.19M –
RTX icon
85
RTX Corp
RTX
$251B
– –
-6,000
Closed -$1.16M –
RVMD icon
86
Revolution Medicines
RVMD
$40.9B
– –
-556
Closed -$54.1K –
SHAZ icon
87
SharonAI Holdings
SHAZ
$1.09B
– –
-25,000
Closed -$568K –

Similar funds

Bleichroeder LP's Q2 2026 Portfolio in Review

As of Q2 2026, Bleichroeder LP held 87 positions worth $559M, down 3.4% from $579M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Bleichroeder LP's Q2 2026 filing shows 6 new, 9 increased, 8 reduced and 9 closed positions. Its largest new stake was Cogent Biosciences: 100,000 shares worth $3.87M. The largest sale was Linde, an estimated $4.07M.

By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, down from 44% a quarter earlier, followed by Industrials and Healthcare.

  • Bleichroeder LP's largest Q2 2026 buy was Cogent Biosciences: 100,000 shares worth $3.87M.
  • Bleichroeder LP added most to LiqTech in Q2 2026, an estimated $5.92M increase.
  • Bleichroeder LP's biggest Q2 2026 reduction was Linde, cutting an estimated $4.07M.
  • Bleichroeder LP fully exited Precision Optics in Q2 2026, selling an estimated $1.19M.
  • Bleichroeder LP's ten largest holdings make up 78% of its $559M portfolio in Q2 2026.
  • Bleichroeder LP opened 6 new positions and closed 9 in Q2 2026.
  • Bleichroeder LP's portfolio value fell 3.4% quarter-over-quarter to $559M.

Based on Bleichroeder LP's 13F filing for Q2 2026, filed 13 Aug 2026.